Skip to main content
logo
Ocugen, Inc. (FRA:2H51)
Germany flag Germany · Delayed Price · Currency is EUR
1.229
-0.038 (-3.00%)
At close: Jan 30, 2026

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '20 Dec '13 Dec '12
Novel Gene and Cell Therapies, Biologics and Vaccines
4.05M
Novel Gene and Cell Therapies, Biologics and Vaccines Growth
-32.82%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '20 Dec '13 Dec '12
United States
4.05M
United States Growth
-32.82%